Should You Hold DexCom (DXCM)?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 2,781,588 | $259,522,160 | +47% | 0.13% |
| 2. | Holocene Advisors Brandon Haley | 2,585,897 | $241,264,190 | +62% | 1.05% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,190,804 | $111,102,016 | -28% | 0.22% |
| 4. | Fisher Asset Management Ken Fisher | 1,011,622 | $94,384,347 | -21% | 0.05% |
| 5. | Citadel Investment Group Ken Griffin | 943,650 | $88,042,545 | +266% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.01 | 25,000 | Director | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | Director | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | Director | 121,975 | 2013-03-11 | Filing | |
| $10.37 | 1,000 | Director | 6,000 | 2012-03-08 | Filing | |
| $10.34 | 1,000 | Director | 5,000 | 2012-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $115.42 | 1,170 | Officer | 58,394 | 2023-12-01 | Filing | |
| $114.43 | 1,542 | Officer | 59,564 | 2023-12-01 | Filing | |
| $113.64 | 900 | Officer | 61,106 | 2023-12-01 | Filing | |
| $93.27 | 2,725 | Officer | 47,725 | 2023-11-09 | Filing | |
| $110.80 | 411 | Officer | 124,775 | 2023-11-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 44,189,005 | $4,122,834,166 | 0.1% | |
| 2. | 32,742,829 | $3,054,905,917 | 0.08% | |
| 3. | 29,585,000 | $2,788,386,250 | 0.56% | |
| 4. | 16,682,504 | $1,556,477,623 | 1.46% | |
| 5. | 16,035,459 | $1,496,108,325 | 0.08% |
News See All
11 Best Long Term Growth Stocks To Invest In
In this piece, we will look at the 11 best long-term growth stocks to invest in.
Goldman Sachs' Top 15 Stock Picks for 2024
In this piece, we will take a look at Goldman Sachs' top 15 stock picks for 2024.
5 Best Medical Technology Stocks To Buy Now
In this article, we discuss 5 of the best medical device stocks to buy now.
13 Stocks That Outperform the S&P 500 Every Year for the Last 5 Years
In this article, we will take a look at the 13 stocks that outperform the S&P 500 every year for the last 5 years.
Investors’ Concerns over the Impact of GLP-1 Drugs Dragged DexCom (DXCM)
Fred Alger Management, an investment management company, released its “Alger Mid Cap Focus Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
12 Best Internet of Things (IoT) Stocks To Buy
In the last several decades, technology has undergone significant evolution. It's not just computers and smartphones that are now connected to the internet.
5 Undervalued Mid Cap Stocks To Buy
In this piece, we will take a look at the five undervalued mid cap stocks to buy.
5 Best Long-term Stocks To Buy For High Returns
In this piece, we will take a look at the five best long term stocks to buy for high returns.
Dexcom (DXCM) Faces Challenges Over GLP-1s' Long-Term Effects on Its Target Market
The Ithaka Group, an investment advisory firm, released the “Ithaka US Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
